MC
LLY icon

Moors & Cabot’s Eli Lilly LLY Stock Holding History

Moors & Cabot’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14
Closed -$3K – 688
2020
Q1 		$3K Buy
+14
New +$1.92K ﹤0.01% 586
2019
Q3 		– Sell
-1,600
Closed -$1K – 684
2019
Q2 		$1K Buy
+1,600
New +$188K ﹤0.01% 554
2016
Q4 		– Sell
-2,000
Closed -$3K – 566
2016
Q3 		$3K Buy
+2,000
New +$160K ﹤0.01% 544
2016
Q2 		– Sell
-2,000
Closed -$1K – 535
2016
Q1 		$1K Buy
+2,000
New +$151K ﹤0.01% 519

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moors & Cabot's LLY Position: Q2 2026 in Review

Moors & Cabot reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $419K and leaving 22,840 shares worth $27.4M. The position accounts for 1.07% of the portfolio, ranked #12.

Moors & Cabot first reported a position in LLY in Q1 2014 and has held it in 50 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Moors & Cabot held 22,840 shares of Eli Lilly worth $27.4M as of Q2 2026.
  • Moors & Cabot sold 410 Eli Lilly shares in Q2 2026, an estimated $419K.
  • Eli Lilly made up 1.07% of Moors & Cabot's portfolio in Q2 2026, its #12 holding.
  • Moors & Cabot first reported a position in Eli Lilly in Q1 2014 and has held it in 50 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.